A randomised control trial to assess efficacy of fluticasone nasal spay in controlling symptoms of allergic rhinitis as compared to combination of fluticasone nasal spray and orally taken vitamin D

Does topical intranasal steroid spray with oral Vit D results in better control of allergic rhinitis compared to topical intranasal spray alone: A Randomised Control Trial - Not applicable

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056332

Enrollment

Registered

2023-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Fluticasone propionate nasal spray 0.05%: Fluticasone propionate nasal spray 0.05% W/v. 2 spary in each nostril twice daily for 3 months . Topical intranasal glucocorticoid with potent

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed cases of allergic rhinitis Patients detected to have Vitamin D deficiency

Exclusion criteria

Exclusion criteria: uncertain diagnosis of Allergic diagnosis Females who are pregnant and breastfeeding Patient receiving steroid, immunomodulatory drugs, B-blocker, herbal, ayurvedic or complementary medicine Patient showing manifestation of Vitamin D deficiency Known cases of Asthama, COPD, sinonasal polyposis Patients unable to respond to scoring system

Design outcomes

Primary

Measure	Time frame
Total nasal symptom ScoreTimepoint: At time of enrollment At one month At three month	—

Secondary

Measure	Time frame
Serum Vitamin D levelTimepoint: At time of enrollment At three month	—

Countries

India

Contacts

Public ContactKamal Deep Joshi

Command Hospital, Western Comd

kdeepjoshi10@gmail.com7507088660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026